Miami Cancer Institute Names Geoffrey Young, M.D., Ph.D., Chief of Head and Neck Cancer Surgery
MIAMI, FLA. (March 27, 2018) — Miami Cancer Institute at Baptist Health South Florida, the state’s only member of the Memorial Sloan Kettering Cancer Alliance, has announced that Geoffrey Young, M.D., Ph.D., will serve as chief of the division of Head and Neck Cancer Surgery. Dr. Young specializes in the surgical treatment of cancers affecting the head and neck region, including melanomas of the skin occurring above the clavicles. He has special expertise and experience in trans oral robotic surgery and trans oral laser microsurgery — the advanced procedure that utilizes a robotic surgical system that leads to fewer complications and quicker recoveries for his patients. With the Institute’s multidisciplinary care paradigm, Dr. Young will collaborate with other clinical experts in head and neck cancer to provide patients with comprehensive, individualized treatment.
Dr. Young received his medical degree from the University of Alabama School of Medicine in Birmingham, Ala., and a Doctor of Philosophy degree in molecular and cellular pathology from the University of Alabama. He completed a residency in general surgery at Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey in New Brunswick, N.J. His post-doctoral training included a fellowship in head and neck surgery at The Johns Hopkins Hospital, Johns Hopkins School of Medicine in Baltimore, Md. Dr. Young comes to Miami Cancer Institute from Mayo Clinic in Jacksonville, Fla., where he served as assistant professor of otolaryngology at Mayo Clinic School of Medicine.
“Dr. Young brings specialized expertise in the treatment of head and neck cancers and is well prepared to lead the development of clinical and research initiatives that seek to improve treatment options and patient outcomes,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “Our patients will benefit from his skills and experience in the treatment of head and neck cancers, as these tumors are some of the rarest in the United States and many doctors have little to no experience treating these difficult cancers.”
Dr. Young’s research efforts focus on cancer immunology and molecular biology to further the understanding of disease processes and improve methods for diagnosis, prevention and treatment of disease. He has presented his clinical findings at numerous national and international scientific conferences. He serves on the editorial review Board of The Scientific Pages of Head and Neck Surgery and as a trainer for the Academy of Communication in Healthcare. He is a member of several professional medical organizations, including the American College of Surgeons, the American Head and Neck Society and the American Thyroid Association.
# # #
About Miami Cancer Institute
Miami Cancer Institute is a destination cancer center known for its leading clinical care, compassionate patient experience, clinical research and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean, and the only radiation oncology program in the world with each of the latest radiation therapies in one place. The Institute offers robust roster of prominent physicians established in the community, in addition to renowned cancer experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. As Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures the standards of care developed by our multidisciplinary disease management teams match those at MSK. Heralded nationally as one of the new “hybrid” cancer centers of the future, Miami Cancer Institute combines well-established, high-quality community-based cancer care with the best of an academic cancer center – subspecialty-trained surgeons, radiation oncologists and medical oncologists who are national experts and innovators in their fields. For more information, visit MiamiCancerInstitute.com.
Miami Cancer Institute, part of Baptist Health South Florida, the largest healthcare organization in the region, with 10 hospitals (Baptist Hospital, Baptist Children’s Hospital, Bethesda Hospital East, Bethesda Hospital West, Doctors Hospital, Fishermen’s Community Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), more than 40 physician practices, 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence spanning across Monroe, Miami-Dade, Broward and Palm Beach counties. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has more than 19,500 employees and more than 3,000 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net/newsroom and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.
